# New Global Guidelines Warn Against Obesity Drugs for Children Under 10
The World Health Organization has released new global guidelines recommending against using obesity medications for children under 10 years old, according to BBC Health.
The WHO guidance emphasizes that care for young children with obesity should prioritize healthy eating habits and physical exercise rather than pharmaceutical interventions like weight-loss injections. This recommendation reflects the organization's position that lifestyle approaches form the foundation of obesity management in this age group.
The guidelines address growing concerns about the use of medications such as GLP-1 receptor agonists, which have gained popularity for weight management in recent years. These injectable drugs have become increasingly common in clinical practice, prompting the WHO to establish clearer boundaries around their appropriate use in pediatric populations.
The organization's stance underscores the importance of early intervention through behavioral and environmental modifications. For children under 10, the focus remains on establishing sustainable habits around nutrition and activity levels rather than relying on pharmacological solutions.
This guidance applies globally and affects how healthcare providers approach childhood obesity treatment across different countries and healthcare systems. The WHO's recommendation aims to ensure that youngest children receive age-appropriate care strategies that address the root causes of weight gain without the risks associated with medication use in developing bodies.
Healthcare providers are expected to use these guidelines when making treatment recommendations for obese children in this age group, prioritizing family-based interventions and lifestyle changes as the primary approach to managing weight.